Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 948–949 | Cite as

GLUT1 Variants for Predicting Prognosis After Surgery in Non-small Cell Lung Cancer

  • Shin Yup LeeEmail author
  • Jae Yong ParkEmail author
ASO Author Reflections



Shin Yup Lee and Jae Yong Park have no conflicts of interest to disclose.


  1. 1.
    Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.CrossRefGoogle Scholar
  2. 2.
    Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703–7.CrossRefGoogle Scholar
  3. 3.
    Do SK, Jeong JY, Lee SY, et al. Glucose transporter 1 gene variants predict the prognosis of patients with early-stage non-small cell lung cancer. Ann Surg Oncol. 2018;25:3396–3403.CrossRefGoogle Scholar
  4. 4.
    Goodwin J, Neugent ML, Lee SY, et al. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nat. Commun. 2017;8:15503.CrossRefGoogle Scholar
  5. 5.
    Lee SY, Jin CC, Choi JE, et al. Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer. Sci Rep. 2016;6:35603.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Lung Cancer CenterKyungpook National University Chilgok HospitalDaeguKorea
  2. 2.Department of Internal Medicine, School of MedicineKyungpook National UniversityDaeguKorea

Personalised recommendations